Publications by authors named "V Tchesnokova"

A critical step in infections is the attachment of many microorganisms to host cells using lectins that bind surface glycans, making lectins promising antimicrobial targets. Upon binding mannosylated glycans, FimH, the most studied lectin adhesin of type 1 fimbriae in , undergoes an allosteric transition from an inactive to an active conformation that can act as a catch-bond. Monoclonal antibodies that alter FimH glycan binding in various ways are available, but the mechanisms of these antibodies remain unclear.

View Article and Find Full Text PDF

Background: Antibiotic prescription practices differ between countries, influencing regional antimicrobial resistance prevalence. However, comparisons of clonal diversity among resistant bacteria in countries with different prescribing practices are rare. The rise of fluoroquinolone-resistant (FQREC), often multidrug-resistant, exacerbates global antibiotic resistance.

View Article and Find Full Text PDF

Background: Community-acquired UTI is the most common bacterial infection managed in general medical practice that can lead to life-threatening outcomes. While UTIs are primarily caused by colonizing the patient's gut, it is unclear whether the gut resident profiles can predict the person's risks for UTI and optimal antimicrobial treatments. Thus, we conducted an eighteen-month long community-based observational study of fecal colonization and UTI in women aged 50 years and above.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines the impact of decreased ciprofloxacin prescriptions on the prevalence of ciprofloxacin-resistant E. coli in the gut of non-antibiotic-taking women aged 50+ from 2015 to 2021.
  • Despite the reduction in prescriptions, the rates of ciprofloxacin-resistant E. coli increased from 14.2% to 19.8%, particularly in the multi-drug resistant group ST1193.
  • The research suggests that managing gut microbiota is crucial for tackling urinary tract infections that are resistant to current antibiotics, as co-resistance to other antibiotics also rose significantly.
View Article and Find Full Text PDF

Fluoroquinolone use for urinary tract infections has been steadily declining. Gut microbiota is the main reservoir for uropathogenic but whether the carriage of fluoroquinolone-resistant has been changing is unknown. .

View Article and Find Full Text PDF